Current Edition

acute myeloid leukemia

ASH: Astellas looks for silver linings in failed Xospata combo trial

Eying growth in oncology, Astellas has suffered an R&D setback for acute myeloid leukemia drug Xospata (gilteritinib). The med flunked a combo trial with Bristol …

Continue Reading →
acute myeloid leukemia

Bayer targets 100% green packaging for consumer health brands by 2030 as part of €100 million sustainability plan

Eying growth in oncology, Astellas has suffered an R&D setback for acute myeloid leukemia drug Xospata (gilteritinib). The med flunked a combo trial with Bristol …

Continue Reading →